Cargando…

Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?

Pulmonary arterial hypertension (PAH) is a rare, complex, and progressive disease that is characterized by the abnormal remodeling of the pulmonary arteries that leads to right ventricular failure and death. Although our understanding of the causes for abnormal vascular remodeling in PAH is limited,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurakula, Kondababu, Smolders, Valérie F. E. D., Tura-Ceide, Olga, Jukema, J. Wouter, Quax, Paul H. A., Goumans, Marie-José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827874/ https://www.ncbi.nlm.nih.gov/pubmed/33435311 http://dx.doi.org/10.3390/biomedicines9010057

Ejemplares similares

The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression
por: Smolders, Valérie F. E. D., et al.
Publicado: (2021)

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension
por: Tura-Ceide, Olga, et al.
Publicado: (2021)

Endothelial dysfunction in pulmonary arterial hypertension: loss of cilia length regulation upon cytokine stimulation
por: Dummer, Anneloes, et al.
Publicado: (2018)

The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient
por: Happé, Chris, et al.
Publicado: (2020)

Thoracic Aortic Aneurysm Development in Patients with Bicuspid Aortic Valve: What Is the Role of Endothelial Cells?
por: van de Pol, Vera, et al.
Publicado: (2017)

Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling
por: Kurakula, Kondababu, et al.
Publicado: (2015)

Metabolic Alterations in Cardiopulmonary Vascular Dysfunction
por: Smolders, Valérie Françoise, et al.
Publicado: (2019)

Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension
por: Nukala, Sarath Babu, et al.
Publicado: (2021)

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
por: Smolders, V. F. E. D., et al.
Publicado: (2022)

Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention
por: Sanada, Takayuki Jujo, et al.
Publicado: (2021)

Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling
por: Kurakula, Kondababu, et al.
Publicado: (2021)

Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells
por: Szulcek, Robert, et al.
Publicado: (2020)

Updated Perspectives on Pulmonary Hypertension in COPD
por: Blanco, Isabel, et al.
Publicado: (2020)

Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension
por: Poyatos, Paula, et al.
Publicado: (2023)

Endothelial Dysfunction in Experimental Models of Arterial Hypertension: Cause or Consequence?
por: Bernatova, Iveta
Publicado: (2014)

Blood Flow Disturbances in Congenital Heart Disease: Is Neuroblastoma Suppressor of Tumorigenicity 1 a Target for Preventing Pulmonary Vascular Remodeling?
por: Tura-Ceide, Olga
Publicado: (2022)

Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension
por: Gomez‐Puerto, Maria Catalina, et al.
Publicado: (2019)

Endothelial Dysfunction and Cardiovascular Risk in Obstructive Sleep Apnea: A Review Article
por: Peracaula, Miriam, et al.
Publicado: (2022)

Endothelial Colony Forming Cells as an Autologous Model to Study Endothelial Dysfunction in Patients with a Bicuspid Aortic Valve
por: van de Pol, Vera, et al.
Publicado: (2019)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice
por: Bakker, Wineke, et al.
Publicado: (2021)

Association Between Systemic and Pulmonary Vascular Dysfunction in COPD
por: Piccari, Lucilla, et al.
Publicado: (2020)

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)

Linking In Vitro Models of Endothelial Dysfunction with Cell Senescence
por: Jimenez Trinidad, Francisco R., et al.
Publicado: (2021)

Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease
por: García-Lucio, Jéssica, et al.
Publicado: (2018)

Circulating Progenitor Cells and Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
por: Pizarro, Sandra, et al.
Publicado: (2014)

Imaging the TGFβ type I receptor in pulmonary arterial hypertension
por: Rotteveel, Lonneke, et al.
Publicado: (2023)

Generation of a Novel In Vitro Model to Study Endothelial Dysfunction from Atherothrombotic Specimens
por: Gallogly, Susan, et al.
Publicado: (2021)

Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction
por: Zabini, Diana, et al.
Publicado: (2012)

Effects of 6-mercaptopurine in pressure overload induced right heart failure
por: Axelsen, Julie Birkmose, et al.
Publicado: (2019)

Go with the flow…..
por: Quax, Paul H A, et al.
Publicado: (2022)

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
por: Garcia, Agustin R., et al.
Publicado: (2023)

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
por: Hudson, Jaylen, et al.
Publicado: (2021)

Non-Invasive Assessment of Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Dara, Athanasia, et al.
Publicado: (2021)

Sex-biased TGFβ signalling in pulmonary arterial hypertension
por: Wits, Marius, et al.
Publicado: (2023)

Cigarette smoke challenges bone marrow mesenchymal stem cell capacities in guinea pig
por: Tura-Ceide, Olga, et al.
Publicado: (2017)

Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets
por: Ayyoub, Sana, et al.
Publicado: (2023)

TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
por: Rol, Nina, et al.
Publicado: (2018)

Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ibcmlst6pgqg9nbp2gobrlldrr